Eli Lilly and Boehringer Ingelheim cut investment in Germany due to proposed healthcare spending reductions, impacting the pharmaceutical industry and insurance subsidies.

Willkie Farr & Gallagher LLP enhances its German operations by adding M&A and private equity expert Dr. Sebastian Häfele as partner in Munich, reinforcing its transactional capabilities and expanding market footprint.

Germany's pay-as-you-go public pension system struggles with demographic decline and industrial job losses, requiring significant federal subsidies and sparking political debate over contributions.